Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | $19.21M | $0.30 | $10.00 | 3,255.70% | Buy | 2 | 481.39% | N/A | N/A | N/A | ||||
| INTZ | INTRUSION INC | $2.96M | $1.52 | $50.00 | 3,189.47% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| ASLN | ASLAN PHARMACEUTICALS LTD | $7.84M | $0.42 | $9.50 | 2,161.90% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| PPBT | PURPLE BIOTECH LTD | $10.49M | $0.53 | $10.50 | 1,884.88% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| IQ | IQIYI INC | $4.74B | $4.94 | $94.00 | 1,804.76% | Strong Buy | 3 | 5.23% | 11.41% | N/A | N/A | ||||
| GOEV | CANOO INC | $162.93M | $2.53 | $40.35 | 1,494.86% | Strong Buy | 5 | 924.84% | N/A | N/A | N/A | ||||
| CLNN | CLENE INC | $49.70M | $0.39 | $6.00 | 1,450.39% | Strong Buy | 2 | 107.41% | N/A | N/A | N/A | ||||
| LIFE | ATYR PHARMA INC | $118.70M | $1.72 | $25.50 | 1,382.56% | Buy | 2 | 431.52% | N/A | N/A | N/A | ||||
| BPTH | BIO-PATH HOLDINGS INC | $1.91M | $2.81 | $40.00 | 1,323.49% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| CLDI | CALIDI BIOTHERAPEUTICS INC | $8.24M | $0.23 | $3.25 | 1,300.86% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| KZR | KEZAR LIFE SCIENCES INC | $59.48M | $0.82 | $11.00 | 1,246.39% | Buy | 2 | 47.18% | N/A | N/A | N/A | ||||
| BIOL | BIOLASE INC | $5.66M | $0.17 | $2.20 | 1,164.37% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| APTO | APTOSE BIOSCIENCES INC | $19.33M | $1.23 | $15.33 | 1,146.59% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| CKPT | CHECKPOINT THERAPEUTICS INC | $55.67M | $1.56 | $19.00 | 1,117.95% | Strong Buy | 2 | 1,423.38% | N/A | N/A | N/A | ||||
| LYRA | LYRA THERAPEUTICS INC | $23.59M | $0.39 | $4.50 | 1,062.79% | Buy | 3 | 98.72% | N/A | N/A | N/A | ||||
| GOSS | GOSSAMER BIO INC | $168.76M | $0.75 | $8.60 | 1,052.82% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| AADI | AADI BIOSCIENCE INC | $46.16M | $1.88 | $20.50 | 990.43% | Strong Buy | 2 | 33.42% | N/A | N/A | N/A | ||||
| APLM | APOLLOMICS INC | $35.53M | $0.40 | $4.25 | 970.53% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| MVST | MICROVAST HOLDINGS INC | $138.61M | $0.44 | $4.50 | 929.75% | Buy | 4 | 31.17% | N/A | N/A | N/A | ||||
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | $5.56M | $1.81 | $18.50 | 922.10% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| OCUP | OCUPHIRE PHARMA INC | $48.63M | $1.96 | $20.00 | 920.41% | Strong Buy | 2 | 46.92% | N/A | N/A | N/A | ||||
| LUXH | LUXURBAN HOTELS INC | $29.65M | $0.71 | $7.00 | 887.31% | Strong Buy | 2 | 43.83% | N/A | N/A | N/A | ||||
| VIRX | VIRACTA THERAPEUTICS INC | $32.40M | $0.83 | $7.67 | 829.33% | Buy | 3 | N/A | N/A | N/A | N/A | ||||
| YTEN | YIELD10 BIOSCIENCE INC | $3.77M | $5.87 | $54.00 | 819.93% | Buy | 2 | 658.60% | N/A | N/A | N/A | ||||
| FEMY | FEMASYS INC | $28.22M | $1.27 | $11.67 | 818.66% | Strong Buy | 3 | 211.85% | N/A | N/A | N/A | ||||
| TARA | PROTARA THERAPEUTICS INC | $61.36M | $2.98 | $26.50 | 789.26% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| MIST | MILESTONE PHARMACEUTICALS INC | $90.35M | $1.70 | $15.00 | 782.35% | Strong Buy | 2 | 402.59% | N/A | N/A | N/A | ||||
| INAB | IN8BIO INC | $44.57M | $1.01 | $8.83 | 774.55% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $59.75M | $2.14 | $18.50 | 764.49% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| IMRX | IMMUNEERING CORP | $46.26M | $1.56 | $13.40 | 758.97% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| EVA | ENVIVA INC | $39.33M | $0.53 | $4.50 | 752.27% | Buy | 2 | 25.14% | N/A | N/A | N/A | ||||
| SYBX | SYNLOGIC INC | $21.31M | $1.83 | $15.50 | 746.99% | Buy | 2 | 86.35% | N/A | N/A | N/A | ||||
| BNED | BARNES & NOBLE EDUCATION INC | $16.69M | $0.31 | $2.63 | 735.99% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| EOSE | EOS ENERGY ENTERPRISES INC | $137.39M | $0.68 | $5.67 | 735.84% | Strong Buy | 3 | 365.13% | N/A | N/A | N/A | ||||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $11.52M | $0.81 | $6.50 | 702.47% | Strong Buy | 2 | N/A | N/A | -10,239.47% | -7,579.68% | ||||
| PGEN | PRECIGEN INC | $321.11M | $1.29 | $10.00 | 675.19% | Buy | 2 | 198.74% | N/A | N/A | N/A | ||||
| PRST | PRESTO AUTOMATION INC | $13.65M | $0.17 | $1.31 | 675.15% | Buy | 2 | 27.03% | N/A | N/A | N/A | ||||
| GNLX | GENELUX CORP | $108.53M | $4.02 | $31.00 | 671.14% | Buy | 2 | 2,779.57% | N/A | N/A | N/A | ||||
| MRNS | MARINUS PHARMACEUTICALS INC | $76.08M | $1.39 | $10.50 | 658.12% | Buy | 6 | 64.53% | N/A | N/A | N/A | ||||
| GEVO | GEVO INC | $178.59M | $0.76 | $5.68 | 651.72% | Buy | 3 | 73.38% | N/A | N/A | N/A | ||||
| VOR | VOR BIOPHARMA INC | $123.55M | $1.81 | $13.50 | 645.86% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| MBRX | MOLECULIN BIOTECH INC | $10.65M | $4.78 | $35.00 | 632.22% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| FBIO | FORTRESS BIOTECH INC | $32.89M | $1.71 | $12.50 | 630.99% | Strong Buy | 2 | 25.32% | N/A | N/A | N/A | ||||
| LUMO | LUMOS PHARMA INC | $24.48M | $3.02 | $22.00 | 628.48% | Buy | 2 | 180.56% | N/A | N/A | N/A | ||||
| CVKD | CADRENAL THERAPEUTICS INC | $7.76M | $0.49 | $3.50 | 621.65% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| TPST | TEMPEST THERAPEUTICS INC | $77.09M | $3.47 | $25.00 | 620.46% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| SGMT | SAGIMET BIOSCIENCES INC | $145.85M | $4.57 | $32.75 | 616.63% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| IKNA | IKENA ONCOLOGY INC | $65.15M | $1.35 | $9.50 | 603.70% | Buy | 2 | 61.57% | N/A | N/A | N/A | ||||
| ACET | ADICET BIO INC | $133.91M | $1.63 | $11.33 | 595.28% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| OTLK | OUTLOOK THERAPEUTICS INC | $100.59M | $7.73 | $53.57 | 592.98% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| DDC | DDC ENTERPRISE LTD | N/A | $0.80 | $5.50 | 586.64% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| SGMO | SANGAMO THERAPEUTICS INC | $108.53M | $0.52 | $3.50 | 569.22% | Buy | 2 | 64.82% | N/A | N/A | N/A | ||||
| AQMS | AQUA METALS INC | $50.83M | $0.45 | $3.00 | 560.79% | Buy | 2 | 1,334.38% | N/A | N/A | N/A | ||||
| IVA | INVENTIVA SA | $178.76M | $3.43 | $22.33 | 551.11% | Strong Buy | 3 | -1.30% | N/A | N/A | N/A | ||||
| PASG | PASSAGE BIO INC | $81.17M | $1.46 | $9.50 | 550.68% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| CMPS | COMPASS PATHWAYS PLC | $583.97M | $8.54 | $55.33 | 547.93% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| SPRB | SPRUCE BIOSCIENCES INC | $34.48M | $0.84 | $5.40 | 544.39% | Buy | 5 | 84.64% | N/A | N/A | N/A | ||||
| HOOK | HOOKIPA PHARMA INC | $79.16M | $0.80 | $5.00 | 525.00% | Buy | 2 | -42.32% | N/A | N/A | N/A | ||||
| CLRB | CELLECTAR BIOSCIENCES INC | $104.52M | $3.24 | $20.00 | 517.28% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| GRTS | GRITSTONE BIO INC | $105.64M | $0.97 | $6.00 | 516.65% | Buy | 2 | 75.79% | N/A | N/A | N/A | ||||
| CARA | CARA THERAPEUTICS INC | $41.54M | $0.76 | $4.63 | 508.55% | Buy | 4 | -24.56% | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.